Peter Auguste

1.3k total citations
44 papers, 857 citations indexed

About

Peter Auguste is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Economics and Econometrics. According to data from OpenAlex, Peter Auguste has authored 44 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Economics and Econometrics. Recurrent topics in Peter Auguste's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Multiple Sclerosis Research Studies (4 papers). Peter Auguste is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Multiple Sclerosis Research Studies (4 papers). Peter Auguste collaborates with scholars based in United Kingdom, France and Switzerland. Peter Auguste's co-authors include Tracy Roberts, Rachel Court, Aileen Clarke, Paul Sutcliffe, Alexander Tsertsvadze, Pelham Barton, Joshua Pink, Hema Mistry, Martin Connock and Karoline Freeman and has published in prestigious journals such as The Lancet, PLoS ONE and Thorax.

In The Last Decade

Peter Auguste

36 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Auguste United Kingdom 17 338 184 171 154 152 44 857
Anand N. Malaviya India 24 211 0.6× 147 0.8× 228 1.3× 201 1.3× 114 0.8× 101 1.6k
Gwen M. Allardice United Kingdom 11 108 0.3× 85 0.5× 109 0.6× 106 0.7× 68 0.4× 13 692
Manuel F. Ugarte‐Gil Peru 21 199 0.6× 158 0.9× 326 1.9× 156 1.0× 96 0.6× 126 1.6k
Barbara L. Kroner United States 27 347 1.0× 96 0.5× 346 2.0× 102 0.7× 250 1.6× 75 2.5k
Eric Chokunonga France 17 324 1.0× 80 0.4× 61 0.4× 132 0.9× 186 1.2× 33 1.1k
Benjamin Emmanuel United States 17 303 0.9× 23 0.1× 131 0.8× 83 0.5× 104 0.7× 53 824
Marcus M. Monroe United States 21 164 0.5× 50 0.3× 67 0.4× 320 2.1× 167 1.1× 64 1.1k
Primal Kaur United States 16 169 0.5× 116 0.6× 65 0.4× 198 1.3× 392 2.6× 34 1.8k
Ian S D Roberts United Kingdom 19 104 0.3× 660 3.6× 45 0.3× 284 1.8× 132 0.9× 43 2.0k
Colin Hessel United States 14 711 2.1× 105 0.6× 157 0.9× 141 0.9× 595 3.9× 25 2.1k

Countries citing papers authored by Peter Auguste

Since Specialization
Citations

This map shows the geographic impact of Peter Auguste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Auguste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Auguste more than expected).

Fields of papers citing papers by Peter Auguste

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Auguste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Auguste. The network helps show where Peter Auguste may publish in the future.

Co-authorship network of co-authors of Peter Auguste

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Auguste. A scholar is included among the top collaborators of Peter Auguste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Auguste. Peter Auguste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geppert, Julia, Peter Auguste, Hesam Ghiasvand, et al.. (2025). Software with artificial intelligence-derived algorithms for detecting and analysing lung nodules in CT scans: systematic review and economic evaluation. Health Technology Assessment. 29(14). 1–234. 3 indexed citations
2.
Elfeky, Adel, Adam Boulton, Rachel Court, et al.. (2025). Innovative ventilation technologies used in the intensive care unit for adults and children: a scoping review. NIHR Open Research. 5. 1–1.
4.
Miller, Michelle A., Ly‐Mee Yu, Peter Auguste, et al.. (2024). FOUND Trial: randomised controlled trial study protocol for case finding of obstructive sleep apnoea in primary care using a novel device. BMJ Open. 14(7). e090000–e090000.
5.
Geppert, Julia, Emma Helm, Daniel Todkill, et al.. (2024). Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies. Thorax. 79(11). 1040–1049. 15 indexed citations
7.
Connock, Martin, et al.. (2023). Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair. PLoS ONE. 18(1). e0280554–e0280554. 1 indexed citations
8.
Stinton, Chris, Mary Jordan, Hannah Fraser, et al.. (2021). Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation. Health Technology Assessment. 25(42). 1–216. 10 indexed citations
9.
10.
Armoiry, Xavier, Jean‐François Obadia, Peter Auguste, & Martin Connock. (2020). Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation. PLoS ONE. 15(11). e0241361–e0241361. 1 indexed citations
11.
Auguste, Peter, Jill L Colquitt, Martin Connock, et al.. (2020). Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 38(6). 527–536. 10 indexed citations
12.
Gallacher, Daniel, Peter Auguste, & Martin Connock. (2019). How Do Pharmaceutical Companies Model Survival of Cancer Patients? A Review of NICE Single Technology Appraisals in 2017. International Journal of Technology Assessment in Health Care. 35(2). 160–167. 16 indexed citations
13.
14.
15.
Gallacher, Daniel, Xavier Armoiry, Peter Auguste, et al.. (2018). Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 37(1). 19–27. 9 indexed citations
16.
Auguste, Peter, Alexander Tsertsvadze, Joshua Pink, et al.. (2017). Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis. BMC Infectious Diseases. 17(1). 200–200. 106 indexed citations
17.
Freeman, Karoline, Sian Taylor‐Phillips, Martin Connock, et al.. (2017). Test accuracy of drug and antibody assays for predicting response to antitumour necrosis factor treatment in Crohn’s disease: a systematic review and meta-analysis. BMJ Open. 7(6). e014581–e014581. 11 indexed citations
18.
Auguste, Peter, Alexander Tsertsvadze, Rachel Court, & Joshua Pink. (2016). A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in high-risk groups. Tuberculosis. 99. 81–91. 12 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026